The Blood Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Glucose Testing, Lipid Panel Testing, Prostate Specific Antigen (PSA) Testing, Blood Urea Nitrogen (BUN) Testing, Thyroid Stimulating Hormone Testing, Others), By Method (Manual Blood Testing, Automated Blood Testing), By End-User (Diagnostic Laboratories, Hospitals, Others).
An Introduction to Blood Testing Market in 2024
The Blood Testing market in 2024 serves the demand for diagnostic tests and assays performed on blood samples to assess various physiological parameters, detect biomarkers, and diagnose diseases and medical conditions affecting the cardiovascular, hematological, endocrine, and immune systems. Blood testing encompasses a wide range of laboratory and point-of-care tests such as complete blood count (CBC), blood chemistry panels, coagulation tests, blood typing and crossmatching, infectious disease screening, and therapeutic drug monitoring, providing valuable information for clinical assessment, treatment decisions, and disease monitoring. Market dynamics are driven by factors such as the increasing prevalence of chronic diseases and infectious diseases, advancements in laboratory automation and point-of-care testing technology, and the growing demand for personalized and predictive medicine. Collaboration between diagnostic companies, healthcare providers, and regulatory agencies drives innovation and market growth in blood testing, supporting improved patient outcomes and disease management across various medical specialties and healthcare settings.
A prominent trend in the Blood Testing market is the increasing adoption of Point-of-Care Testing (POCT) solutions. POCT allows for rapid and decentralized blood testing, enabling healthcare providers to obtain real-time results at the patient's bedside or in remote settings. This trend is driven by the need for timely diagnosis, monitoring, and management of various medical conditions, including infectious diseases, chronic illnesses, and acute conditions. POCT solutions offer benefits such as reduced turnaround time, improved patient outcomes, enhanced workflow efficiency, and increased accessibility to testing in underserved areas. As a result, there is growing demand for POCT devices and assays across healthcare settings, including hospitals, clinics, ambulatory care centers, and community healthcare facilities.
A key driver for the Blood Testing market is the rising incidence of chronic diseases and infectious conditions globally. Chronic diseases such as diabetes, cardiovascular diseases, and cancer, along with infectious conditions like HIV/AIDS, hepatitis, and COVID-19, require regular blood testing for diagnosis, monitoring, and treatment management. The increasing prevalence of these conditions, coupled with aging populations and lifestyle changes, is fueling the demand for blood testing services and products. Additionally, advancements in blood testing technologies, including automation, miniaturization, and multiplexing, are enabling more accurate and efficient detection of biomarkers and analytes, further driving market growth.
One potential opportunity in the Blood Testing market lies in the expansion of blood testing services in emerging markets. Emerging economies are witnessing rapid urbanization, industrialization, and healthcare infrastructure development, leading to increased access to healthcare services and rising healthcare spending. However, many of these regions still face challenges related to disease burden, limited healthcare resources, and gaps in diagnostic capabilities. By investing in the expansion of blood testing services, companies can address unmet medical needs, improve disease detection and management, and contribute to better health outcomes in these markets. Moreover, strategic partnerships, technology transfer agreements, and capacity-building initiatives can facilitate the adoption of advanced blood testing technologies and ensure sustainable market growth in emerging economies.
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux SA
BioRad Laboratories
Danaher Corp
F. Hoffmann-La Roche AG
Novartis International AG
PerkinElmer Inc
Shimadzu Corp
Thermo Fisher Scientific
Una Health Ltd
Waters Corp
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Blood Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Blood Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Blood Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Blood Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Blood Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Blood Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Blood Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Blood Testing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Blood Testing Market Industry
4.2 Key Market Trends in Blood Testing Market Industry
4.3 Potential Opportunities in Blood Testing Market Industry
4.4 Key Challenges in Blood Testing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Blood Testing Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Blood Testing Market Outlook By Segments
7.1 Blood Testing Market Outlook by Segments
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
8 North America Blood Testing Market Analysis And Outlook To 2030
8.1 Introduction to North America Blood Testing Markets in 2024
8.2 North America Blood Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Blood Testing Market size Outlook by Segments, 2021-2030
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
9 Europe Blood Testing Market Analysis And Outlook To 2030
9.1 Introduction to Europe Blood Testing Markets in 2024
9.2 Europe Blood Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Blood Testing Market Size Outlook By Segments, 2021-2030
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
10 Asia Pacific Blood Testing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Blood Testing Markets in 2024
10.2 Asia Pacific Blood Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Blood Testing Market size Outlook by Segments, 2021-2030
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
11 South America Blood Testing Market Analysis And Outlook To 2030
11.1 Introduction to South America Blood Testing Markets in 2024
11.2 South America Blood Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Blood Testing Market size Outlook by Segments, 2021-2030
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
12 Middle East And Africa Blood Testing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Blood Testing Markets in 2024
12.2 Middle East and Africa Blood Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Blood Testing Market size Outlook by Segments, 2021-2030
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux SA
BioRad Laboratories
Danaher Corp
F. Hoffmann-La Roche AG
Novartis International AG
PerkinElmer Inc
Shimadzu Corp
Thermo Fisher Scientific
Una Health Ltd
Waters Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Glucose Testing
Lipid Panel Testing
Prostate Specific Antigen (PSA) Testing
Blood Urea Nitrogen (BUN) Testing
Thyroid Stimulating Hormone Testing
Other Types (Direct LDL testing, Testosterone Testing)
By Methods
Manual Blood Testing
Automated Blood Testing
By End-User
Diagnostic Laboratories
Hospitals
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Blood Testing Market is one of the lucrative growth markets, poised to register a 7.1% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, BioRad Laboratories, Danaher Corp, F. Hoffmann-La Roche AG, Novartis International AG, PerkinElmer Inc, Shimadzu Corp, Thermo Fisher Scientific, Una Health Ltd, Waters Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume